Search results
Author(s):
David Power
Added:
1 year ago
Outcomes investigating the Absorb bioresorbable vascular scaffold (BVS) in patients undergoing percutaneous coronary intervention showed more adverse ischaemic events through 5 years compared with cobalt-chromium everolimus-eluting stents. However, the period of excess risk ended at 3 years.In this short interview, Dr David Power (Mount Sinai Hospital, New York, US) discusses the final report…
View more
Author(s):
Samineh Sehatbakhsh
Added:
9 months ago
Navigate the complex landscape of coronary interventions following transcatheter aortic valve replacement with Dr Samineh Sehatbakhsh, addressing critical access challenges in an era of expanding TAVR indications.This essential presentation, part of the Complex Cases track, examines the growing clinical significance of post-TAVR coronary access as procedures expand to younger, lower-risk patients…
View more
Anomalous Coronary Artery Origin
Author(s):
Luai Madanat
,
Ahmad Jabri
,
Michael Gallagher
,
et al
Added:
1 year ago
Case Report
Assessing Coronary Angiography Interpretation Education
Author(s):
Kayla A Riggs
,
Jay Gopal
,
Carson Keck
,
et al
Added:
1 year ago
Original Research
MI and Non-obstructive Coronary Arteries
Author(s):
Yetunde A Fatade
,
Noah A Newman
,
Nidhi H Patel
,
et al
Added:
1 year ago
Review Article
Author(s):
Tomas Kovarnik , Mohamed Ayoub, Giuseppe Di Gioia ,et al
Start date:
Jun 03, 2024
Join us for a transformative broadcast, chaired by Dr Tomáš Kovárník (Charles University, Prague, CZ), showcasing the latest advancements in CTO PCI procedures with state-of-the-art technology.Investigate the possibility of shortening stent lengths with precision physiology guidance, featuring Dr Mohamed Ayoub's (University Heart Center NRW, Bad Oeynhausen, DE) presentationExplore the combination…
View more
Author(s):
Ajay J Kirtane
Added:
2 months ago
ACC.26 – Dr Ajay Kirtane (NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, US) discusses the ALL-RISE trial (NCT05893498), a large-scale, global, prospective, randomised, multicentre study comparing FFRangio-based, angiography-derived coronary physiology with conventional pressure wire-guided FFR/NHPR to direct PCI in patients with coronary artery disease.This pivotal non…
View more
Yoshi Onuma
Job title: Director of Coronary Imaging and Atherosclerosis Research
Author
Author(s):
Matthias Bossard
Added:
7 months ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus…
View more